Try our Advanced Search for more refined results

Fed. Circ. Lifts Lupin Ban In Generic Fortamet Fight

By Zach Winnick (February 6, 2012, 8:35 PM EST) -- The Federal Circuit on Monday reversed an order requiring Lupin Ltd. to stop selling its generic version of Type 2 diabetes treatment Fortamet, vacating the preliminary injunction on grounds that the lower court hadn't considered Lupin's obviousness defense in the patent infringement suit....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!